1. Home
  2. CING
  3. CING News

Latest Cingulate Inc. (CING) News on June 7, 2025

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD
CING

GlobeNewswire

18 days ago

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD

CING: First Quarter 2025 Results
CING

Zacks Small Cap Research

23 days ago

CING: First Quarter 2025 Results

FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301
CING

GlobeNewswire

24 days ago

FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
CING

GlobeNewswire

a month ago

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets

Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD
CING

GlobeNewswire

a month ago

Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD

Cingulate secures $3m to advance once-daily anxiety treatment
CING

Pharmaceutical Technology

2 months ago

Cingulate secures $3m to advance once-daily anxiety treatment

CING: 2024 Financial and Operational Results
CING

Zacks Small Cap Research

2 months ago

CING: 2024 Financial and Operational Results

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)
CING

GlobeNewswire

2 months ago

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301
CING

GlobeNewswire

2 months ago

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301

Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
CING

GlobeNewswire

2 months ago

Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved

CING: April Pre-NDA Meeting
CING

Zacks Small Cap Research

3 months ago

CING: April Pre-NDA Meeting

Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
CING

GlobeNewswire

3 months ago

Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025

Final Study Completed for Cingulate’s Lead Asset CTx-1301
CING

GlobeNewswire

5 months ago

Final Study Completed for Cingulate’s Lead Asset CTx-1301

Cingulate Inc Secures $5M Financing for Strategic Growth
CING

TipRanks

5 months ago

Cingulate Inc Secures $5M Financing for Strategic Growth

CING

MT Newswires

5 months ago

Cingulate's Shares Rise After $5 Million Capital Raise

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
CING

GlobeNewswire

5 months ago

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

CING

Zacks Small Cap Research

7 months ago

CING: Third Quarter Results

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
CING

GlobeNewswire

7 months ago

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
CING

GlobeNewswire

8 months ago

Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
CING

GlobeNewswire

9 months ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Cingulate to Participate in Benzinga All Live Access Event
CING

GlobeNewswire

9 months ago

Cingulate to Participate in Benzinga All Live Access Event

CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
CING

Zacks Small Cap Research

9 months ago

CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage

CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
CING

Zacks Small Cap Research

9 months ago

CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage

Cingulate Announces Adjournment of Special Meeting
CING

GlobeNewswire

9 months ago

Cingulate Announces Adjournment of Special Meeting

CING

MT Newswires

10 months ago

Top Midday Decliners

CING

MT Newswires

10 months ago

Cingulate Says Lincoln Park Capital Fund to Offer 1 Million Shares; Increases At-The-Market Offering Limit to $11.3 Million

CING

MT Newswires

10 months ago

Top Premarket Gainers

CING

MT Newswires

10 months ago

Top Midday Gainers

Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
CING

GlobeNewswire

10 months ago

Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD

Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved
CING

GlobeNewswire

10 months ago

Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved

CING

MT Newswires

a year ago

Cingulate Files Prospectus for Resale of Up to 6.6 Million Common Shares

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds
CING

GlobeNewswire

a year ago

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
CING

GlobeNewswire

a year ago

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event

Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance
CING

GlobeNewswire

a year ago

Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
CING

GlobeNewswire

a year ago

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
CING

GlobeNewswire

a year ago

Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
CING

GlobeNewswire

a year ago

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access

CING

ACCESSWIRE

a year ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
CING

GlobeNewswire

a year ago

Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024

Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
CING

GlobeNewswire

a year ago

Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update

Cingulate to Participate in Benzinga All Live Access Event
CING

GlobeNewswire

a year ago

Cingulate to Participate in Benzinga All Live Access Event

Cingulate to Attend DCAT Week 2024 in New York City
CING

GlobeNewswire

a year ago

Cingulate to Attend DCAT Week 2024 in New York City

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
CING

GlobeNewswire

a year ago

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

Cingulate Announces Closing of $7.5 Million Public Offering
CING

GlobeNewswire

a year ago

Cingulate Announces Closing of $7.5 Million Public Offering

Cingulate Announces Pricing of $7.5 Million Public Offering
CING

GlobeNewswire

a year ago

Cingulate Announces Pricing of $7.5 Million Public Offering

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
CING

Business Wire

a year ago

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Bullfrog AI Announces Pricing of $5.7 Million Public Offering
CING

GlobeNewswire

a year ago

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

CING

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/30/2024

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
CING

GlobeNewswire

a year ago

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO
CING

GlobeNewswire

a year ago

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
CING

GlobeNewswire

a year ago

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market

CING

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/29/2024

Best Momentum Stocks to Buy for January 26th
CING

Zacks

a year ago

Best Momentum Stocks to Buy for January 26th

ISG to Publish Report Assessing eMobility Services and Solutions Providers
CING

Business Wire

a year ago

ISG to Publish Report Assessing eMobility Services and Solutions Providers

AI Shows Signs of Maturity, Expansion in Brazil
CING

Business Wire

a year ago

AI Shows Signs of Maturity, Expansion in Brazil

Good Times Restaurants to Release First Quarter Financial Results on January 31, 2024
CING

Business Wire

a year ago

Good Times Restaurants to Release First Quarter Financial Results on January 31, 2024

Red Cat Integrates Advanced AI Capabilities into Next-Generation Drone System for the U.S. Army’s Short Range Reconnaissance Program
CING

GlobeNewswire

a year ago

Red Cat Integrates Advanced AI Capabilities into Next-Generation Drone System for the U.S. Army’s Short Range Reconnaissance Program

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
CING

Business Wire

a year ago

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

CareCloud Elevates Pathology Practice siParadigm with Cutting-Edge CareCloud Central Platform
CING

GlobeNewswire

a year ago

CareCloud Elevates Pathology Practice siParadigm with Cutting-Edge CareCloud Central Platform

20 Countries with the Highest Plastic Surgery Rates per Capita
CING

Insider Monkey

a year ago

20 Countries with the Highest Plastic Surgery Rates per Capita

2U, Inc.'s (NASDAQ:TWOU) Intrinsic Value Is Potentially 18% Below Its Share Price
CING

Simply Wall St.

a year ago

2U, Inc.'s (NASDAQ:TWOU) Intrinsic Value Is Potentially 18% Below Its Share Price

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital
CING

Simply Wall St.

a year ago

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital

Tonix Pharmaceuticals Presents Additional Data Highlighting the Favorable Tolerability and Differentiated Side Effect Profile of TNX-102 SL in Second Positive Phase 3 Clinical Trial for the Management of Fibromyalgia
CING

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presents Additional Data Highlighting the Favorable Tolerability and Differentiated Side Effect Profile of TNX-102 SL in Second Positive Phase 3 Clinical Trial for the Management of Fibromyalgia

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada
CING

ACCESSWIRE

a year ago

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada

Syra Health Announces its Sponsorship of ViVE 2024
CING

PR Newswire

a year ago

Syra Health Announces its Sponsorship of ViVE 2024

Positive Signs As Multiple Insiders Buy BioCardia Stock
CING

Simply Wall St.

a year ago

Positive Signs As Multiple Insiders Buy BioCardia Stock

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024
CING

GlobeNewswire

a year ago

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
CING

PR Newswire

a year ago

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering

CING

InvestorPlace

a year ago

Why Is Cingulate (CING) Stock Up 160% Today?

CING

Investing.com

a year ago

Midday movers: Microsoft, AMD, Boeing, and more

Tandy Leather Factory (NASDAQ:TLF) Has Some Difficulty Using Its Capital Effectively
CING

Simply Wall St.

a year ago

Tandy Leather Factory (NASDAQ:TLF) Has Some Difficulty Using Its Capital Effectively

Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 1.2% More Shares
CING

Simply Wall St.

a year ago

Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 1.2% More Shares

Safeguard Scientifics Announces Stock Split Ratios to Effectuate the Going Dark Transaction
CING

GlobeNewswire

a year ago

Safeguard Scientifics Announces Stock Split Ratios to Effectuate the Going Dark Transaction

Nephros, Inc.'s (NASDAQ:NEPH) P/S Is Still On The Mark Following 40% Share Price Bounce
CING

Simply Wall St.

a year ago

Nephros, Inc.'s (NASDAQ:NEPH) P/S Is Still On The Mark Following 40% Share Price Bounce

Costco's (COST) Q1 Earnings Top, Comparable Sales Up 3.8%
CING

Zacks

a year ago

Costco's (COST) Q1 Earnings Top, Comparable Sales Up 3.8%

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism
CING

GlobeNewswire

a year ago

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

Chanson International Holding Announces the Plan to Grow Its New Coffee Brand in China
CING

GlobeNewswire

a year ago

Chanson International Holding Announces the Plan to Grow Its New Coffee Brand in China

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts
CING

GlobeNewswire

a year ago

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts

Envirotech Vehicles Announces Pilot Program with Crossno Corp., a Regional FedEx Ground Contractor
CING

ACCESSWIRE

a year ago

Envirotech Vehicles Announces Pilot Program with Crossno Corp., a Regional FedEx Ground Contractor

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive
CING

Simply Wall St.

2 years ago

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer
CING

Business Wire

2 years ago

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer

Carbon Revolution Announces First Fiscal Quarter FY2024 Business Update Conference Call Date
CING

GlobeNewswire

2 years ago

Carbon Revolution Announces First Fiscal Quarter FY2024 Business Update Conference Call Date

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
CING

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

Selina Hospitality PLC Provides Update Regarding Fundraising and Liability Management Efforts
CING

Business Wire

2 years ago

Selina Hospitality PLC Provides Update Regarding Fundraising and Liability Management Efforts

Bradley Radoff Bought 9.4% More Shares In Harte Hanks
CING

Simply Wall St.

2 years ago

Bradley Radoff Bought 9.4% More Shares In Harte Hanks

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
CING

GlobeNewswire

2 years ago

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

Xcel Brands, Inc. to Present at Upcoming Investor Conferences
CING

GlobeNewswire

2 years ago

Xcel Brands, Inc. to Present at Upcoming Investor Conferences

CING

PR Newswire

2 years ago

Aetherium Acquisition Corp. Receives Additional Staff Determination Letter from Nasdaq

CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
CING

GlobeNewswire

2 years ago

CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction

Jianpu Technology Inc. (NYSE:JT) Q3 2023 Earnings Call Transcript
CING

Insider Monkey

2 years ago

Jianpu Technology Inc. (NYSE:JT) Q3 2023 Earnings Call Transcript

CING

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Symbotic Inc Earnings Call

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript
CING

Insider Monkey

2 years ago

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript

Geospace Technologies Corporation (NASDAQ:GEOS) Q4 2023 Earnings Call Transcript
CING

Insider Monkey

2 years ago

Geospace Technologies Corporation (NASDAQ:GEOS) Q4 2023 Earnings Call Transcript

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
CING

Simply Wall St.

2 years ago

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

HireQuest, Inc. Declares Quarterly Dividend
CING

ACCESSWIRE

2 years ago

HireQuest, Inc. Declares Quarterly Dividend

CING

Associated Press Finance

2 years ago

Homology Medicines: Q3 Earnings Snapshot

Homology Medicines Reports Third Quarter 2023 Financial Results
CING

GlobeNewswire

2 years ago

Homology Medicines Reports Third Quarter 2023 Financial Results

908 Devices Announces MX908 Integration Capabilities
CING

Business Wire

2 years ago

908 Devices Announces MX908 Integration Capabilities

SAI.TECH Global Corporation Reports Unaudited Financial Results for the Six Months Ended June 30, 2023
CING

GlobeNewswire

2 years ago

SAI.TECH Global Corporation Reports Unaudited Financial Results for the Six Months Ended June 30, 2023

Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
CING

GlobeNewswire

2 years ago

Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update

Share on Social Networks: